Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongcheng Liu

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Medical Physics|November 21, 2025
Introducing an innovative IMPT algorithm toward clinic implementation of the MCF MKM RBE model for carbon ion therapyJindong Tong, Hongcheng Liu, Alessio Parisi, et al.
World Journal of Urology|October 29, 2025
Development and validation of a predictive model for adherent perirenal fat based on CT radiomics and deep learningXiaobo Ding, Hongcheng Liu, Xu Li, et al.
Journal for Immunotherapy of Cancer|December 21, 2022
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancerMeng Qiao, Fei Zhou, Xinyu Liu, et al.
Journal of Colloid and Interface Science|September 12, 2024
Efficient generation of singlet oxygen (<sup>1</sup>O<sub>2</sub>) by CoP/Ni<sub>2</sub>P@NF for degradation of sulfamerazine through a heterogeneous electro-Fenton process at circumneutral pHChunhui Yu, Hongcheng Liu, Chenlin Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 25, 2013
MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancerHuijun Zhang, Hui Zhang, Mingchuan Zhao, et al.
Journal of Healthcare Engineering|October 8, 2021
mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung CancerPeixin Chen, Shengyu Wu, Jia Yu, et al.
Antibodies (Basel, Switzerland)|November 22, 2022
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge VariantsAlain Beck, Christine Nowak, Deborah Meshulam, et al.
Mabs|March 8, 2018
Analytical comparability study of recombinant monoclonal antibody therapeuticsAlexandre Ambrogelly, Stephen Gozo, Amit Katiyar, et al.
Pharmaceutical Research|June 27, 2024
Stability of Protein Pharmaceuticals: Recent AdvancesMark Cornell Manning, Ryan E Holcomb, Robert W Payne, et al.
Mabs|December 14, 2018
Structure, heterogeneity and developability assessment of therapeutic antibodiesYingda Xu, Dongdong Wang, Bruce Mason, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Medical Physics|November 21, 2025
Introducing an innovative IMPT algorithm toward clinic implementation of the MCF MKM RBE model for carbon ion therapyJindong Tong, Hongcheng Liu, Alessio Parisi, et al.
World Journal of Urology|October 29, 2025
Development and validation of a predictive model for adherent perirenal fat based on CT radiomics and deep learningXiaobo Ding, Hongcheng Liu, Xu Li, et al.
Journal for Immunotherapy of Cancer|December 21, 2022
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancerMeng Qiao, Fei Zhou, Xinyu Liu, et al.
Journal of Colloid and Interface Science|September 12, 2024
Efficient generation of singlet oxygen (<sup>1</sup>O<sub>2</sub>) by CoP/Ni<sub>2</sub>P@NF for degradation of sulfamerazine through a heterogeneous electro-Fenton process at circumneutral pHChunhui Yu, Hongcheng Liu, Chenlin Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 25, 2013
MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancerHuijun Zhang, Hui Zhang, Mingchuan Zhao, et al.
Journal of Healthcare Engineering|October 8, 2021
mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung CancerPeixin Chen, Shengyu Wu, Jia Yu, et al.
Antibodies (Basel, Switzerland)|November 22, 2022
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge VariantsAlain Beck, Christine Nowak, Deborah Meshulam, et al.
Mabs|March 8, 2018
Analytical comparability study of recombinant monoclonal antibody therapeuticsAlexandre Ambrogelly, Stephen Gozo, Amit Katiyar, et al.
Pharmaceutical Research|June 27, 2024
Stability of Protein Pharmaceuticals: Recent AdvancesMark Cornell Manning, Ryan E Holcomb, Robert W Payne, et al.
Mabs|December 14, 2018
Structure, heterogeneity and developability assessment of therapeutic antibodiesYingda Xu, Dongdong Wang, Bruce Mason, et al.
Pageof 18